Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer

Urology

Volumn 54, Issue 3, 1999, Pages 523-527

  Duque, Jose Luis F ^b   Loughlin, Kevin R ^b   Adam, Rosalyn M ^b   Kantoff, Philip W ^b   Zurakowski, David ^b   Freeman, Michael R ^a  

^a Enders Research Laboratories   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; VASCULOTROPIN;

ADULT; AGE; AGED; ARTICLE; BONE METASTASIS; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SCORING SYSTEM; STANDARD;

AGED; BONE NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHATIC METASTASIS; LYMPHOKINES; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032818964     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00167-3     Document Type: Article

References (17)

1. Ferrara N, and Davis-Smith T: The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25, 1997.
2. Claffey KP, and Robinson GS: Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis. Cancer Metastasis Rev 15: 165-176, 1996.
3. Kumar H, Heer K, Lee PWR, et al: Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res 4: 1279-1285, 1998.
4. Viac J, Schmitt D, and Claudy A: Circulating vascular endothelial growth factor (VEGF) is not a prognostic indicator in malignant melanoma. Cancer Lett 125: 35-38, 1998.
5. Salven P, Ruotsalainen T, Mattson K, et al: High pretreatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer. Int J Cancer 79: 144-146, 1998.
6. Yamamoto Y, Toi M, Kondo S, et al: Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin Cancer Res 2: 821-826, 1996.
7. Salven P, Maenpaa H, Orpana A, et al: Serum vascular endothelial growth factor is often elevated in disseminated cancer. Clin Cancer Res 3: 647-651, 1997.
8. Banks RE, Forbes MA, Kinsey SE, et al: Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 77: 956-964, 1998.
9. Webb NJ, Bottomley MJ, Watson CJ, et al: Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci 94: 395-404, 1998.
10. Dosquet C, Coudert M-C, Lepage E, et al: Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma? Clin Cancer Res 3: 2451-2458, 1997.
11. Jin-No K, Tanimizu M, Hyodo I, et al: Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma. J Gastroenterol 33: 376-382, 1998.
12. McGill R, Tukey JW, and Larsen WA: Variations of box plots. Am Stat 32: 12-16, 1978.
13. Hosmer DW, and Lemeshow S: Applied Logistic Regression. New York, John Wiley, 1989, pp 33-37.
14. Ferrer FA, Miller LJ, Andrawis RI, et al: Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells. J Urol 157: 2329-2333, 1997.
15. Freeman MR, Schneck FX, Gagnon ML, et al: Peripheral blood T lymphocytes infiltrating human cancer express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res 55: 4140-4145, 1995.
16. Wasada T, Kavahara R, Katsumori K, et al: Plasma concentration of immunoreactive vascular endothelial growth factor and its relation to smoking. Metabolism 47: 27-30, 1998.
17. Zhong H, Agani F, Baccala AA, et al: Increased expression of hypoxia indu cible factor-1α in rat and human prostate cancer. Cancer Res 58: 5280-5284, 1998.